Lam Research Corp Valuation – April 2019 #LRCX
Company Profile (excerpt from Reuters): Lam Research Corporation, incorporated on October 8, 1989, is a supplier of wafer fabrication equipment and services to the semiconductor industry. The Company designs, manufactures, markets, refurbishes and services semiconductor processing systems that are used in the fabrication of integrated circuits (ICs). The Company operates through manufacturing and servicing of wafer processing semiconductor manufacturing equipment segment. The Company’s products are designed to enable its customers build a range of devices that are used in a range of electronic products, including cell phones, tablets, computers, storage devices and networking equipment. The Company’s customer base includes semiconductor memory, foundry and integrated device manufacturers (IDMs) that make products, such as dynamic random-access memory (DRAM), negative-AND (NAND) memory and logic devices. The Company offers a portfolio of products that are used in several areas of the semiconductor manufacturing process flow, including thin film deposition, plasma etch and single-wafer clean. The Company also offers a range of services, including customer service, spares, upgrades, and refurbishment of its deposition, etch and clean products. The Company also provides refurbished legacy products.
Downloadable PDF version of this valuation:
ModernGraham Valuation of LRCX – April 2019
Stage 1: Is this company suitable for the Defensive Investor or the Enterprising Investor?
What kind of Intelligent Investor are you?
Defensive Investor; must pass 6 out of the following 7 tests. | ||||
1. Adequate Size of the Enterprise | Market Cap > $2Bil | $29,332,951,738 | Pass | |
2. Sufficiently Strong Financial Condition | Current Ratio > 2 | 3.39 | Pass | |
3. Earnings Stability | Positive EPS for 10 years prior | Pass | ||
4. Dividend Record | Dividend Payments for 10 years prior | Fail | ||
5. Earnings Growth | Increase of 33% in EPS in past 10 years using 3 year averages at beginning and end | 259.29% | Pass | |
6. Moderate PEmg Ratio | PEmg < 20 | 18.10 | Pass | |
7. Moderate Price to Assets | PB Ratio < 2.5 OR PB*PEmg < 50 | 5.34 | Fail | |
Enterprising Investor; must pass 4 out of the following 5 tests, or be suitable for the Defensive Investor. | ||||
1. Sufficiently Strong Financial Condition | Current Ratio > 1.5 | 3.39 | Pass | |
2. Sufficiently Strong Financial Condition | Debt to NCA < 1.1 | 0.35 | Pass | |
3. Earnings Stability | Positive EPS for 5 years prior | Pass | ||
4. Dividend Record | Currently Pays Dividend | Pass | ||
5. Earnings Growth | EPSmg greater than 5 years ago | Pass |
Stage 2: Determination of Intrinsic Value
EPSmg | $10.63 |
MG Growth Estimate | 15.00% |
MG Value | $409.23 |
Opinion | Undervalued |
MG Grade | B- |
MG Value based on 3% Growth | $154.13 |
MG Value based on 0% Growth | $90.35 |
Market Implied Growth Rate | 4.80% |
Current Price | $192.35 |
% of Intrinsic Value | 47.00% |
Lam Research Corporation is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the poor dividend history, and the high PB ratio. The Enterprising Investor has no initial concerns. As a result, all Enterprising Investors following the ModernGraham approach should feel comfortable proceeding with the analysis.
As for a valuation, the company appears to be Undervalued after growing its EPSmg (normalized earnings) from $2.9 in 2015 to an estimated $10.63 for 2019. This level of demonstrated earnings growth outpaces the market’s implied estimate of 4.8% annual earnings growth over the next 7-10 years. As a result, the ModernGraham valuation model, based on the Benjamin Graham value investing formula, returns an estimate of intrinsic value above the price.
At the time of valuation, further research into Lam Research Corporation revealed the company was trading above its Graham Number of $110.67. The company pays a dividend of $2.55 per share, for a yield of 1.3% Its PEmg (price over earnings per share – ModernGraham) was 18.1, which was below the industry average of 35.4, which by some methods of valuation makes it one of the most undervalued stocks in its industry. Finally, the company was trading above its Net Current Asset Value (NCAV) of $14.98.
Lam Research Corporation performs fairly well in the ModernGraham grading system, scoring a B-.
Stage 3: Information for Further Research
Net Current Asset Value (NCAV) | $14.98 |
Graham Number | $110.67 |
PEmg | 18.10 |
Current Ratio | 3.39 |
PB Ratio | 5.34 |
Current Dividend | $2.55 |
Dividend Yield | 1.33% |
Number of Consecutive Years of Dividend Growth | 5 |
Useful Links:
ModernGraham tagged articles | Morningstar |
Google Finance | MSN Money |
Yahoo Finance | Seeking Alpha |
GuruFocus | SEC Filings |
Most Recent Balance Sheet Figures
Balance Sheet Information | 12/1/2018 |
Total Current Assets | $7,355,845,000 |
Total Current Liabilities | $2,166,837,000 |
Long-Term Debt | $1,813,190,000 |
Total Assets | $10,768,458,000 |
Intangible Assets | $1,736,468,000 |
Total Liabilities | $4,927,086,000 |
Shares Outstanding (Diluted Average) | 162,170,000 |
Earnings Per Share History
EPS History | |
Next Fiscal Year Estimate | $12.98 |
Jun2018 | $13.17 |
Jun2017 | $9.24 |
Jun2016 | $5.22 |
Jun2015 | $3.70 |
Jun2014 | $3.62 |
Jun2013 | $0.66 |
Jun2012 | $1.35 |
Jun2011 | $5.79 |
Jun2010 | $2.71 |
Jun2009 | -$2.41 |
Jun2008 | $3.47 |
Jun2007 | $4.85 |
Jun2006 | $2.33 |
Jun2005 | $2.09 |
Jun2004 | $0.54 |
Jun2003 | -$0.06 |
Jun2002 | -$0.71 |
Jun2001 | $0.39 |
Jun2000 | $1.53 |
Jun1999 | -$0.98 |
Earnings Per Share – ModernGraham History
EPSmg History | |
Next Fiscal Year Estimate | $10.63 |
Jun2018 | $8.63 |
Jun2017 | $5.74 |
Jun2016 | $3.63 |
Jun2015 | $2.90 |
Jun2014 | $2.61 |
Jun2013 | $1.94 |
Jun2012 | $2.45 |
Jun2011 | $2.96 |
Jun2010 | $1.76 |
Jun2009 | $1.54 |
Jun2008 | $3.23 |
Jun2007 | $2.72 |
Jun2006 | $1.39 |
Jun2005 | $0.76 |
Jun2004 | $0.18 |
Jun2003 | $0.01 |
Recommended Reading:
Other ModernGraham posts about the company
Other ModernGraham posts about related companies
Disclaimer:
The author did not hold a position in any company mentioned in this article at the time of publication and had no intention of changing that position within the next 72 hours.  See my current holdings here.  This article is not investment advice; any reader should speak to a registered investment adviser prior to making any investment decisions.  ModernGraham is not affiliated with the company in any manner.  Please be sure to review our detailed disclaimer.